A protocol for adjusting hypoglycaemic medications for patients on a low carbohydrate diet has been published.
Updated: 07/15/2019 11:37A
NEWTON, MA--(Marketwired - Nov 20, 2015) - Boston Therapeutics, Inc. ( OTCQB : BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of metabolic disease and inflammatory disease states, today ...
Updated: 11/20/2015 04:57P